SCI Abstract

search
+
Benefits of reducing duration of endoscopic duodenal-jejunal bypass liner implantation to nine months in treatment of diabesity
International Diabetes Federation. IDF diabetes atlas, 10th ed., 2021. https://www.diabetesatlas.org...
Severe DKA at presentation in young people - is it always type 1 diabetes?
Diabetes - type 2: What is it? [Internet]. NICE, 2023. Available at: https://cks.nice.org.uk/topics/...
Viewing the doctor-patient relationship through an educational lens: a reflection on running a diabetes clinic
Hopkins D, Lawrence I, Mansell P, et al. Improved biomedical and psychological outcomes 1 year after...
Null variant homozygous familial hypercholesterolaemia: genetic analysis and 34 years follow-up
Goldstein JL, Brown MS. Binding and degradation of low density lipoproteins by cultured human fibrob...
Acknowledgement to BJD 2024 reviewers
...
Implementation of hybrid closed loop therapy in the NHS: experiences from the adult diabetes centre in Derby and Burton
Godoi A, Reis Marques I, Padrão EMH, et al. Glucose control and psychosocial outcomes with use of au...
Exploring the value of peer support for people living with type 1 diabetes
The British Journal of Diabetes is the official journal of ABCD (Diabetes Care), a company limited by shares in Engla...
Is a low-calorie diet (LCD) key to treating type 2 diabetes holistically?
NHS Type 2 Diabetes Path to Remission Programme, 2024. Available from: https://www.england.nhs.uk/di...
DAFNE is agile and responsive—a beacon of best practice
DAFNE Study Training in flexible, intensive insulin management to enable dietary freedom in people w...
What does current diabetes and endocrine speciality outpatient training look like and what will change? Observations from a single training region in England
Authors Jolyon Dales University Hospitals of Leicester NHS...
Managing menopause in women with diabetes
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence ...
Sustainability in diabetes care: building an environment for change
Authors DOI: https://doi.org/10.15277/bjd.2024.457 ...
ABCD 2024 winning posters
...
Time to act? Is the new era of gut hormone-based pharmacotherapy an opportunity to rethink the tier-based UK obesity care model?
Obesity and overweight fact sheets. World Health Organization. 1 March 2024 [cited 2024, 25 November...
A brief review of the 60th Annual Meeting of the EASD 2024
...
Advances in detection, prevention and treatment of heart failure in type 2 diabetes: part II
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart...
Is lasting remission feasible in the real-world setting? Yes!
Taylor R. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologi...
Advances in detection, prevention and treatment of heart failure in type 2 diabetes: part I
Rawshani A, Rawshani A, Franzén S, et al. Risk factors, mortality, and cardiovascular outcomes in pa...
Exploratory outcomes of the use of insulin degludec in the real world: data from the Association of British Clinical Diabetologists nationwide degludec audit
Jonassen I, Havelund S, Hoeg-Jensen T, Steensgaard DB, Wahlund PO, Ribel U. Design of the novel prot...
Real-world cross-comparison of metabolic outcomes with different sodium-glucose co-transporter 2 inhibitors agents in adults with type 2 diabetes: results from the Association of British Clinical Diabetologists audit programme
Real-world cross-comparison of metabolic outcomes with different sodium-glucose co-transporter 2 inhibitors agents in a...
Update on recent advances in technology in type 1 diabetes
Roep BO, Thomaidou S, van Tienhoven R, Zaldumbide A. Type 1 diabetes mellitus as a disease of the β-...
Putting EMPA-REG into practice: a data-driven intervention
Scottish Diabetes Group. Scottish Diabetes Survey 2021. [Internet]. Diabetes in Scotland; 2023 Feb 1...
New approaches to weight loss and glycaemic control in T2DM, focusing on tirzepatide and newer agents
Nauck MA, Meier JJ. The incretin effect in healthy individuals and those with type 2 diabetes: physi...
Diabesity and microvascular disease: the impact of weight loss
Bashir B, Iqbal Z, Adam S, et al. Microvascular complications of diabetes and obesity – role of bari...
A critique of semaglutide (Wegovy®) for obesity management NICE technology appraisal TA875
https://www.nice.org.uk/guidance/ta875; accessed on 5/10/2023 Wilding JPH, Batterham...
Mental capacity, declining insulin injections and multidisciplinary team working
Public Health England. 3.8 million people in England now have diabetes [Internet]. 2016 [cited 2024 ...
Co-existence of type 1 diabetes and monogenic diabetes in one family: getting the diagnosis right
Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and matur...
Abstracts from the 6th Joint Meeting of ABCD & UKKA 2023
...
Abstracts from ABCD Diabetes Update (online only)
...
Supporting remission of type 2 diabetes in the real world
UK Government. https://www.gov.uk/government/organisations/accelerated-access-review. 2016. Accelera...
Load More
format_indent_increase